GHENT, Belgium & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative … [Read more…]
YOKOHAMA, Japan–(BUSINESS WIRE)–CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture, CEO: Yoji Jokura, Ph.D.) announces that the safety evaluation in the safety cohort of its clinical trial for anterior cruciate ligament (ACL) reconstruction with the medical device “Tissue Regenerative Ligament” (development code: CT-ACL001) sponsored by the company has been completed, … [Read more…]
HASLET, Texas–(BUSINESS WIRE)–Davidson Bogel Real Estate (DB2RE) is pleased to announce the sale of approximately 7 acres of land located at the southwest corner of Haslet Parkway and Harmon Road in Haslet, Texas. Collins Meier, Ryan Turner, David Davidson, Jr., and Edward Bogel represented the seller in the transaction. The buyer, Encompass Health, partnered closely … [Read more…]
OLDSMAR, Fla.–(BUSINESS WIRE)–Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that the NYSE American LLC (the “NYSE American”) has accepted the Company’s previously submitted plan to regain compliance with continued listing standards. As previously disclosed on March 12, … [Read more…]
New Facility Will Bring Integrated Care to South Los Angeles, Where Families Lack Reliable Access to Primary Care LOS ANGELES–(BUSINESS WIRE)–#Clinic–Saban Community Clinic (SCC) today breaks ground on its new Crenshaw Family Health Center, a major expansion that will bring comprehensive, community-based healthcare to the heart of South Los Angeles, one of the most underserved … [Read more…]
Landmark 10th Annual Awards Program Recognizes the Deseyne® Extended Depth of Focus (EDOF) contact lens as the “Best New Technology Solution – Ophthalmology” Worldwide BOCA RATON, Fla.–(BUSINESS WIRE)–#ContactLenses–The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that its Deseyne® daily disposable contact lens technology for … [Read more…]
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas, NV. Pulse Biosciences’ Management is scheduled to present on Wednesday, May 13, at 4:35 pm PT. A live and recorded … [Read more…]
Solid Start to 2026 with Disciplined Execution Shareholder Value Creation BELO HORIZONTE, Brazil–(BUSINESS WIRE)–Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the first quarter and three-month period ended March 31, 2026. Financial results … [Read more…]
LONDON–(BUSINESS WIRE)–Asset Value Investors Limited (“AVI”) today announced an update to its public campaign regarding Rohto Pharmaceutical Co., Ltd. (TSE: 4527, “Rohto”), as a follow-up to its ongoing campaign, “Awakening Rohto”, launched last year and aimed at enhancing the company’s corporate value. AVI has published a detailed presentation on a dedicated website (www.AwakeningRohto.com). Since initiating … [Read more…]
— Peer-reviewed publication reports faster decongestion with Reprieve Therapy and no increased risk of safety events or worsening kidney function compared to optimal diuretic therapy — MILFORD, Mass.–(BUSINESS WIRE)–Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) treatment, today announced the publication of results from its FASTR randomized pilot study … [Read more…]
